Gregory Browning
Pain Medicine · Florence, SCNPI 1538175245
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.0% of the total across 246 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by Forte Bio-pharma LLC at 24.5% of the total. Reporting peaked in 2022 at $1,217 and has fallen 90.1% since, to $121 in 2025.
Across 246 payments — averaging $19.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Forte Bio-pharma LLC$1K
- Novo Nordisk$713
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$433
- Scilex Pharmaceuticals Inc.$292
- Boehringer Ingelheim$228
- Biodelivery Sciences International, Inc.$227
- plus $2K from 22 others
What the payments were for
- Food & beverage$4,52196%
- Education$1884%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Forte Bio-pharma LLC | 23 | $1,155 |
| Novo Nordisk | 45 | $713 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 27 | $433 |
| Scilex Pharmaceuticals Inc. | 18 | $292 |
| Boehringer Ingelheim | 10 | $228 |
| Biodelivery Sciences International, Inc. | 15 | $227 |
| AbbVie | 19 | $221 |
| Collegium Pharmaceutical, Inc. | 15 | $204 |
| GSK | 11 | $172 |
| Virtus Pharmaceuticals LLC | 12 | $167 |
| Hikma Pharmaceuticals USA | 9 | $162 |
| Alkermes, Inc. | 6 | $156 |
| Pfizer | 8 | $102 |
| Urovant Sciences Inc | 1 | $90 |
| Zyla Life Sciences, Inc. | 5 | $65 |
| Redhill Biopharma Inc. | 4 | $58 |
| Kaleo, Inc. | 4 | $56 |
| AstraZeneca | 3 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| Nevro Corp. | 1 | $18 |
| Abbott | 1 | $17 |
| GRT US Holding, Inc. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Shire North American Group Inc | 1 | $16 |
| Indivior Inc. | 1 | $14 |
| Amgen | 1 | $13 |
| Lilly USA, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,708 in reported general payments places this provider in the 60th percentile of 92 pain medicine providers in South Carolina.
Other pain medicine in Florence
- Michael WardenFlorence$20K
- Barbara SarbFlorence$11K
- Elizabeth SnoderlyFlorence$5K
- Anna KellyFlorence$1K
- Phillip SmithGreenville$303K
- Richard KlineConway$104K
- Channing WilloughbyMurrells Inlet$82K
- Michael WarrickSumter$50K
- Daniel AtkinsonGreenville$36K
- Andrew MendelsonCharleston$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.